Table 2.
Pregnancy and delivery characteristics and outcomes among parturients diagnosed with COVID-19
| Characteristics | n = 52 |
|---|---|
| Gestational age at delivery | 38 [36–40] (38) |
| < 37 weeks | 17 (32.7%) |
| < 34 weeks | 9 (17.3%) |
| Gestation diabetes mellitus | 6 (11.5%) |
| Gestational hypertensive disorders | 7 (13.4%) |
| Maternal complications | |
| Need for mechanical intubation | 1 (1.9%) |
| Intensive-care unit admission | 1 (1.9%) |
| Venous thromboembolism | 1 (1.9%) |
| HELLP syndrome | 1 (1.9%) |
| Spontaneous onset of labor | 33 (63.5%) |
| Mode of anesthesia | |
| None | 15 (28.8%) |
| General | 2 (3.8%) |
| Regional | 35 (67.3%) |
| Mode of delivery | |
| Vaginal | 39 (75.0%) |
| Pre-labor cesarean | 9 (17.3%) |
| In-labor cesarean | 4 (7.7%) |
| Oxytocin use* | 18 (41.9%) |
| Intrapartum fever* | 3 (7.0%) |
| First-stage duration of labor (minutes) | 112 [51–221] (163) |
| Second-stage duration of labor (minutes) | 12 [7–40] (32) |
| Postpartum hemorrhage | 6 (11.5%) |
| Length of hospitalization (days) | 4 [3–7] (6) |
| Neonatal outcomes | |
| Birthweight (grams) | 3280 [2927–3606] (3140) |
| 5-min Apgar score < 8 | 1 (1.9%) |
| NICU admission | 6 (11.5%) |
| RDS | 6 (11.5%) |
| TTN | 1 (1.9%) |
| Hypoglycemia | 4 (9.3%) |
| Hyperbilirubinemia | 5 (9.6%) |
All continuous variables are expressed as medians [interquartile range] (means)
HELLP hemolysis elevated liver enzymes, and low platelets, RDS respiratory distress syndrome, TTN transient tachypnea of the newborn
*The denominator is the total number of women undergoing a trial of vaginal delivery (n = 43)